Serum prolactin levels and neonatal seizures

Area of Science:

• Neonatal neurology
• Endocrinology
• Clinical diagnostics

Background:

• Neonatal seizures are common and can impact brain development.
• Identifying reliable biomarkers for neonatal seizures is crucial for timely diagnosis and treatment.
• Prolactin, a hormone influenced by the hypothalamus, is being investigated as a potential seizure marker.

Purpose of the Study:

• To evaluate the impact of neonatal seizures on hypothalamic function.
• To assess the clinical utility of serum prolactin levels as a biomarker for neonatal seizures.
• To compare the diagnostic accuracy of prolactin ratios with electroencephalography (EEG).

Main Methods:

• Studied 19 neonates with seizures, classifying them by clinical and EEG features.
• Measured serum prolactin levels postictally (30 min after seizure) and during recovery (2-4 days later).
• Calculated the prolactin ratio (postictal/recovery) and assessed its sensitivity and specificity compared to ictal EEG.

Main Results:

• Infants with electroclinical seizures showed significantly higher prolactin ratios than controls.
• Marked prolactin increases were observed primarily in focal tonic seizures with temporal electrode involvement.
• A prolactin ratio > 2 demonstrated 100% specificity but only 40% sensitivity for seizure detection.

Conclusions:

• Neonatal seizures have variable effects on the hypothalamus.
• The low sensitivity and delayed measurement of prolactin limit its clinical value as a neonatal seizure marker.
• Current diagnostic standards remain superior for identifying neonatal seizures.